Country | Sample Size | Methotrexate | Sulfasalazine | Hydroxychloroquine | ||||
---|---|---|---|---|---|---|---|---|
Men | Women | Men | Women | Men | Women | Men | Women | |
South Africa | 74 (16.9) | 364 (83.1) | 72 (97.3) | 329 (90.7) | 1 (1.4) | 8 (2.2) | 9 (12.2) | 52 (14.3) |
USA | 44 (27.5) | 116 (72.5) | 32 (72.7) | 75 (64.7) | 1 (2.3) | 4 (3.4) | 5 (11.4) | 40 (34.5) |
Portugal | 96 (27.4) | 254 (72.6) | 73 (76.0) | 174 (68.5) | 6 (6.3) | 14 (5.5) | 10 (10.4) | 29 (11.4) |
Netherlands | 173 (31.9) | 370 (68.1) | 70 (40.5) | 157 (42.4) | 24 (13.9) | 60 (16.2) | 24 (13.9) | 95 (25.7) |
Mexico | 11 (8.5) | 119 (91.5) | 10 (90.9) | 68 (57.1) | 0 (0) | 18 (15.1) | 0 (0) | 6 (5.0) |
India | 493 (16.0) | 2580 (84.0) | 342 (69.4) | 1722 (67.0) | 146 (29.6) | 506 (19.6) | 191 (38.7) | 1332 (51.6) |
Ireland | 61 (28.4) | 154 (81.6) | 24 (39.3) | 78 (50.6) | 34 (55.7) | 51 (33.1) | 0 (0) | 15 (9.7) |
UK | 153 (35.9) | 273 (63.1) | 125 (81.7) | 227 (83.2) | 74 (48.4) | 122 (44.7) | 82 (53.6) | 160 (58.6) |
↵* Data from Supplementary Tables 2–93. Values are n (%).